Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
|
Product:
Component 1:
Active Ingredients:
Dosage Form:
Component 2:
Active Ingredients:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Cold & Flu Day + Night PE
Paracetamol 500mg
Phenylephrine hydrochloride 5mg
Tablet
Chlorphenamine maleate 2mg
Paracetamol 500mg
Phenylephrine hydrochloride 5mg
Tablet
PSM Healthcare Limited trading as API Consumer Brands
PSM Healthcare Limited trading as API Consumer Brands, Auckland, New Zealand
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Movantik
Naloxegol Oxalate 14.2mg equivalent to naloxegol 12.5mg
Film coated tablet
AstraZeneca Limited
AstraZeneca AB, Sodertalje, Sweden
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Movantik
Naloxegol Oxalate 28.5mg equivalent to naloxegol 25mg
Film coated tablet
AstraZeneca Limited
AstraZeneca AB, Sodertalje, Sweden
|
Dated this 6th day of April 2018.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).
Gazette.govt.nz